nypost.com Open in urlscan Pro
192.0.66.32  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Close the sidebar
 * News
   * Politics
 * Metro
 * Page Six
 * Sports
   * NFL
   * MLB
   * NBA
   * NHL
   * College Football
   * College Basketball
 * Post Sports+
 * Sports Betting
 * Business
   * Personal Finance
 * Opinion
 * Entertainment
   * TV
   * Movies
   * Music
   * Celebrities
   * Awards
   * Theater
 * Shopping
 * Lifestyle
   * Weird But True
   * Health
     * Fitness
     * Health Care
     * Medicine
     * Men’s Health
     * Women’s Health
     * Mental Health
     * Nutrition
   * Sex & Relationships
   * Viral Trends
   * Human Interest
   * Parenting
   * Fashion & Beauty
   * Food & Drink
   * Travel
 * Real Estate
 * Media
 * Tech
 * Astrology
 * Video
 * Photos
 * Visual Stories
 * Sub Menu 1
   * Today’s Paper
   * Covers
   * Columnists
   * Horoscopes
   * Crosswords & Games
   * Sports Odds
   * Podcasts
   * Careers
 * Sub menu 2
   * Email Newsletters
   * Official Store
   * Home Delivery
   * Tips

Close the sidebar
Menu
 * Facebook
 * Twitter
 * Flipboard
 * WhatsApp
 * Email
 * 

TRENDING NOW

Skip to main content

CBS ANCHOR ADMITS HE COULD NOT FIND A SINGLE PERSON OUTSIDE OF...

KANSAS CITY CHIEFS FAN FOUND FROZEN TO DEATH 'SAW SOMETHING THEY...

ROBERT DE NIRO, 80, CRIES OVER RAISING BABY DAUGHTER: 'I WANT TO...

Politics


WHITE HOUSE PHARMACY UNDER TRUMP DISHED OUT AMBIEN, OTHER CONTROLLED DRUGS TO
INELIGIBLE STAFFERS: REPORT

By Victor Nava

Published Jan. 25, 2024, 7:48 p.m. ET

The White House pharmacy under the Trump administration flouted federal
regulations by doling out prescription pills, including stimulants and
sedatives, to ineligible staffers without keeping adequate records, according to
a scathing government report released this month.

Advertisement

“Severe and systemic problems” were found in “all phases of the White House
Medical Unit’s pharmacy operations,” the Department of Defense’s Office of the
Inspector General found.

“Anything that took place at the White House Clinic was never written down,
never recorded,” one witness interviewed for the DOD’s 80-page report said. “The
only record that you ever had that a patient came in and got any sort of
medication would have been if it was a controlled substance that we were
required to document for the pharmacy.”

But even when dealing with controlled substances – drugs with potential for
abuse and physical dependence – the White House Medical Unit wrote prescriptions
that “often lacked the medical provider and patient information mandated by
[Drug Enforcement Agency] policy.” 

Advertisement

5
“Severe and systemic problems” were found in “all phases of the White House
Medical Unit’s pharmacy operations,” according to the government report. White
House Medical Unit
5
The White House Medical Unit often improperly filled out perscriptions for
controlled drugs, such as Ambien and Provigil. White House Medical Unit

“The White House Medical Unit dispensed non‑emergency controlled medications,
such as Ambien and Provigil, without verifying the patient’s identity,” the
report notes, referring to the sedative used to treat insomnia and the stimulant
prescribed for narcolepsy and sleep apnea, respectively. 

Advertisement

A requisition form included in the inspector general’s report shows the White
House pharmacy ordered these medications by the thousands, and routinely
requested brand name drugs despite regulations requiring pharmacies to stock
cheaper generic equivalents. 


MORE ON: WHITE HOUSE


 * HUNTER'S 'SUGAR BROTHER' AVOIDS QUESTIONS AS LAWYER — EVEN THOUGH HE'S
   'EVERYTHING' TO FIRST SON


 * DEATHS OF NAVY SEALS IN RED SEA A 'PROFOUND LOSS FOR OUR COUNTRY': BIDEN


 * HOUSE PANEL INVESTIGATING CAPITOL RIOT WANTS ACCESS TO FILES DELETED BEFORE
   GOP TOOK CONTROL


 * QATAR ALLEGEDLY HIRED EX-CIA AGENT TO DISCREDIT SEN. TED CRUZ, OTHER
   LAWMAKERS OPPOSED TO HAMAS, MUSLIM BROTHERHOOD

Between 2017 and 2019, the White House Medical Unit spent an estimated $46,500
for brand name Ambien, which is 174 times more expensive than the generic
equivalent.

Over the same three-year period, the unit also spent an estimated $98,000 for
brand name Provigil, which is 55 times more expensive than the generic
equivalent. 

Advertisement

The watchdog agency concluded that White House pharmacy staffers had little to
no oversight, and that their prescribing practices put the health and safety of
patients at risk.

5
A witness told the DOD IG that aides to senior staffers would often come by to
pick up their pills. The DoD OIG

One witness explained to investigators that part of their duties in “the
President’s clinic” would be to pre-pack controlled drugs in zip-lock baggies
ahead of overseas trips, which would routinely be picked up by aides to senior
officials in violation of military guidance.   

Advertisement

“So we would normally make these packets of Ambien and Provigil, and a lot of
times they’d be in like five tablets in a zip‑lock bag,” the witness said. “And
so traditionally, too, we would hand these out. . . . But a lot of times the
senior staff would come by or their staff representatives . . . would come by
the residence clinic to pick it up. And it was very much a, hey, I’m here to
pick this up for Ms. X. And the expectation was we just go ahead and pass it
out.” 

Another witness described one instance in which drugs were given to a White
House official as a “parting gift.” 

“Dr. [X] asked if I could hook up this person with some Provigil as a parting
gift for leaving the White House,” they said. “And at the time, the corpsmen and
the medics, the enlisted corpsmen and the medics, [said] it was okay for us to
dispense Provigil and Ambien without having a provider present.”

Advertisement

“I’m not sure if it was okay as far as, like, what’s medically allowed. But in
the unit, it was authorized for us to do that kind of stuff,” the witness
added. 

5
The DOD IG report examined the White House pharmacy’s practices from 2017-2019,
when former President Donald Trump was in office. AFP/Getty Images
5
The White House Medical Unit provided “free medical care” to far more patients
that were eligible. REUTERS

Advertisement

The investigation found that the White House Medical Unit provided “free medical
care to ineligible” White House Staff by instituting a “health care by proxy”
practice, which included dispensing controlled drugs to ineligible staffers “in
violation of Federal law and regulation and DoD policy.”

About 6,000 White House employees, contractors and government employees received
“health care by proxy” at the White House clinics, according to the report. 

By comparison, only about 60 patients were enrolled at the White House Medical
Unit – which the report notes is intended to “cater to the needs” of only the
“highest of Presidential appointees.”


Ad



SHARE THIS:


Filed under donald trump ,  drugs ,  pharmaceuticals ,  pharmacy ,  prescription
drugs ,  white house ,  1/25/24

TRENDING NOW

 1. CBS anchor admits he could not find a single person outside of New Hampshire
    grocery store who feels 'good about the economy'
 2. Kansas City Chiefs fan found frozen to death 'saw something they shouldn't
    have,' parents claim
 3. Robert De Niro, 80, cries over raising baby daughter: 'I want to be around
    for as long as I can'
 4. Vince McMahon assaulted ex-employee with sex toys named after WWE wrestlers,
    defecated on her head during threesome: bombshell suit
 5. Professional dancer, 25, dead after eating mislabeled cookies from popular
    grocery chain
 6. Couple kept chopped up body of NYC drug dealer in fridge for four months as
    neighbors say ‘everybody in the building knew it’

https://nypost.com/2024/01/25/news/white-house-pharmacy-under-trump-was-fast-and-loose-with-drugs-report-finds/?utm_source=url_sitebuttons&utm_medium=site%20buttons&utm_campaign=site%20buttons
Copy the URL to share
 * Post Sports+
 * Email Newsletters
 * Mobile Apps
 * Contact Us
 * Tips

 * Facebook
 * Twitter
 * Instagram
 * LinkedIn
 * Email
 * YouTube

© 2024 NYP Holdings, Inc. All Rights Reserved
Terms of Use | Privacy

Do Not Sell or Share My Personal Information/Opt-Out
Exit mobile version